Concurrent with the launch of the center, Ingenuity said that the Erasmus MC had licensed its Ingenuity Pathways Analysis software in a deal that will give all researchers at the Erasmus MC access to the product.
In addition to licensing agreement, Ingenuity and the Erasmus MC said that they are collaborating on the development of new algorithms, visualizations, and practical applications in molecular and clinical diagnostics.
Erasmus MC is also involved in "product development in proteomics around applications developed at Ingenuity," Ingenuity said.
In another deal announced last week, the Erasmus MC said that it will collaborate with IT firm Ordina to develop bioinformatics-based diagnostic services.
Ordina and the Erasmus MC plan to provide services to analyze data from microarrays and other platforms.
This article originally appeared in BioInform, a GenomeWeb News publication.